
Canada - TSX Venture Exchange - TSX-V:KLY -
ChartMill assigns a fundamental rating of 0 / 10 to KLY.CA.
ChartMill assigns a valuation rating of 0 / 10 to Kalytera Therapeutics Inc (KLY.CA). This can be considered as Overvalued.
Kalytera Therapeutics Inc (KLY.CA) has a profitability rating of 0 / 10.
The financial health rating of Kalytera Therapeutics Inc (KLY.CA) is 0 / 10.